SCM Lifescience Co., Ltd. (KOSDAQ: 298060)

SCM Lifescience Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	163.15	4,496	6,916	2,890	77.47	4,435
Short-Term Investments	2,120	7,840	2,053	16,754	35,219	19,584
Cash & Short-Term Investments	2,284	12,336	8,970	19,644	35,297	24,019
Cash Growth	-85.47%	37.52%	-54.34%	-44.35%	46.95%	-37.61%
Accounts Receivable	114.12	106.41	5.63	16.8	18.59	14.39
Other Receivables	10.46	19.91	19.7	72.87	59.18	153.8
Receivables	124.57	126.32	25.34	89.66	77.77	168.19
Inventory	542.31	392.06	102.71	279.68	36.02	309.55
Prepaid Expenses	522.43	264.78	227.82	223	311.73	198.14
Other Current Assets	145.03	141.25	714.15	75.52	363.66	213.64
Total Current Assets	3,618	13,260	10,040	20,312	36,086	24,909
Property, Plant & Equipment	12,939	10,254	10,650	11,117	11,544	11,266
Long-Term Investments	1,085	1,085	11,468	21,654	28,167	4,439
Other Intangible Assets	781.11	236.93	302.73	335.32	359.17	375.74
Other Long-Term Assets	449.44	567.69	559.11	627.01	136.21	47.08
Total Assets	18,873	25,404	33,020	54,045	76,292	41,037
Accounts Payable	1.31	-	-	-	-	-
Accrued Expenses	179.3	180.44	107.3	232.79	224.61	178.16
Short-Term Debt	-	-	2,000	-	-	-
Current Portion of Long-Term Debt	-	-	-	5,820	120	120
Current Portion of Leases	250.52	131.05	61.56	269.68	330.72	431.12
Other Current Liabilities	2,423	836.73	2,393	2,387	2,584	13,083
Total Current Liabilities	2,854	1,148	4,562	8,709	3,259	13,812
Long-Term Debt	3,630	3,630	3,630	-	5,820	5,940
Long-Term Leases	179.14	57.02	77.55	81.12	368.64	648.07
Other Long-Term Liabilities	423.42	95.01	239.21	641.8	3,765	239.69
Total Liabilities	7,086	4,930	8,509	9,432	13,213	20,640
Common Stock	10,234	10,234	6,060	6,011	5,937	4,586
Additional Paid-In Capital	178,576	178,514	163,098	161,784	160,144	103,877
Retained Earnings	-179,736	-170,987	-147,026	-124,096	-101,577	-91,944
Treasury Stock	-16.56	-16.56	-	-	-	-
Comprehensive Income & Other	2,730	2,730	2,378	913.54	-1,425	331.15
Total Common Equity	11,787	20,474	24,511	44,613	63,079	16,851
Shareholders' Equity	11,787	20,474	24,511	44,613	63,079	20,397
Total Liabilities & Equity	18,873	25,404	33,020	54,045	76,292	41,037
Total Debt	4,060	3,818	5,769	6,171	6,639	7,139
Net Cash (Debt)	-1,776	8,518	3,201	13,473	28,658	16,880
Net Cash Growth	-	166.12%	-76.24%	-52.99%	69.77%	10.46%
Net Cash Per Share	-86.72	520.43	220.68	1126.01	2701.30	3206.37
Filing Date Shares Outstanding	20.46	20.46	14.54	14.43	14.25	9.22
Total Common Shares Outstanding	20.46	20.46	14.54	14.43	14.25	9.22
Working Capital	764.19	12,112	5,478	11,602	32,827	11,097
Book Value Per Share	576.07	1000.63	1685.22	3092.46	4426.77	1828.38
Tangible Book Value	11,006	20,237	24,208	44,277	62,720	16,475
Tangible Book Value Per Share	537.90	989.05	1664.40	3069.22	4401.57	1787.61
Land	6,967	6,967	6,967	6,967	6,967	6,967
Buildings	2,117	2,117	2,117	2,117	2,114	1,068
Machinery	3,590	3,561	3,472	3,318	2,762	2,485
Construction In Progress	3,043	640.2	577.31	304.92	293.57	223.87

Source: S&P Capital IQ. Standard template. Financial Sources.